EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients

Satoshi Yanagida iD, Yuichi Shoburu iD, Takako Kiyokawa iD, Masami Iwamoto iD, Misato Saito iD, Eitaro Suzuki iD, Daito Noguchi iD, Ayako Kawabata iD, Ryusuke Kaya iD, Toshiyuki Seki iD, Chie Nagata iD, Motoaki Saito iD und 5 weitere

Journal of Gynecologic Oncology · 2026

DOI: 10.3802/jgo.2026.37.e44 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Satoshi Yanagida und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan. syan1114@gmail.com. Hauptthemen laut MEDLINE: Forkhead Box Protein L2, Granulosa Cell Tumor, Telomerase, Ovarian Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Adult-type granulosa cell tumors of the ovary (aGCTs) show ambiguous morphology and may be misdiagnosed as other tumors. Recently, heterozygous FOXL2 C402G mutations and TERT promoter C228T mutation have been reported as diagnostic and prognostic biomarkers of aGCTs. The objective of this study was to identify the characteristics of true aGCT cohort using these biomarkers in 72 aGCT samples. METHODS: FOXL2 and TERT promoter mutational statuses of 64 primary and matched 8 recurrent aGCT samples were assessed. Non-aGCTs were excluded by the combination of FOXL2 mutational analysis and the pathological review. The characteristics and prognosis of molecularly/pathologically confirmed aGCTs (MP-aGCTs) were analyzed. RESULTS: Of 18 FOXL2 wild-type (WT) tumors, 3 were excluded as they were of other histotype. None of 20 samples with the FOXL2 C402G mutation include other histotype. Clinical stage and age were prognostic factors for recurrence. Of the 61 MP-aGCTs, 46 harbored FOXL2 C402G mutation (44 heterozygous, 2 homozygous/hemizygous) and 15 had WT FOXL2. The presence of the FOXL2 mutation was associated with a worse prognosis. The mutational status of the TERT promoter in MP-aGCTs was 10 heterozygous and 51 WT. The TERT promoter mutation was highly identified in older patients and in larger tumors but had no prognostic impact. CONCLUSION: This is the first study to clearly demonstrate its practical application of FOXL2 in the diagnosis of aGCTs. Application of the molecular analysis to a large aGCT cohort is crucial for understanding true characteristics and establishing novel treatment strategy of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein L2Granulosa Cell TumorTelomeraseOvarian NeoplasmsHumansFemalePromoter Regions, GeneticMiddle AgedAdultMutationAgedJapanPrognosisDNA Mutational AnalysisAged, 80 and overBiomarkers, TumorEast Asian People

Stichwörter der Autor:innen

Biomarkers, TumorFOXL2 Transcription FactorGranulosa Cell TumorMutation, MissenseOvaryTERT Protein, Human

Substanzen

Forkhead Box Protein L2FOXL2 protein, humanTERT protein, humanTelomeraseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan. syan1114@gmail.com.
  • Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan. yshoburu@gmail.com.
  • Department of Medicine Pathology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Pathology, Dokkyo Medical University School of Medicine and Graduate School of Medicine, Mibu, Japan.
  • Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, The Jikei University Katsushika Medical Center, Tokyo, Japan.

ORCID-Profile: Satoshi Yanagida, Yuichi Shoburu, Takako Kiyokawa, Masami Iwamoto, Misato Saito, Eitaro Suzuki, Daito Noguchi, Ayako Kawabata, Ryusuke Kaya, Toshiyuki Seki, Chie Nagata, Motoaki Saito, Hirokuni Takano, Kyosuke Yamada, Masataka Takenaka, Nozomu Yanaihara, Aikou Okamoto

Zitieren

APA

Yanagida, S., Shoburu, Y., Kiyokawa, T., Iwamoto, M., Saito, M., Suzuki, E., Noguchi, D., Kawabata, A., Kaya, R., Seki, T., Nagata, C., Saito, M., Takano, H., Yamada, K., Takenaka, M., Yanaihara, N., & Okamoto, A. (2026). Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e44

Vancouver

Yanagida S, Shoburu Y, Kiyokawa T, Iwamoto M, Saito M, Suzuki E, et al. Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e44

BibTeX
@article{Yanagida2026,
  author = {Yanagida, Satoshi and Shoburu, Yuichi and Kiyokawa, Takako and Iwamoto, Masami and Saito, Misato and Suzuki, Eitaro and Noguchi, Daito and Kawabata, Ayako and Kaya, Ryusuke and Seki, Toshiyuki and Nagata, Chie and Saito, Motoaki and Takano, Hirokuni and Yamada, Kyosuke and Takenaka, Masataka and Yanaihara, Nozomu and Okamoto, Aikou},
  title = {Molecular and pathological analysis of FOXL2 and TERT promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  doi = {10.3802/jgo.2026.37.e44}
}
Kostenlos starten →